2021
DOI: 10.1002/14651858.cd013362.pub2
|View full text |Cite
|
Sign up to set email alerts
|

Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 22 publications
(14 citation statements)
references
References 231 publications
0
11
0
1
Order By: Relevance
“…Biliary leak Cholescintigraphy NA [5] Gallstones ERCP PTC [6,7] Cholecystitis Cholescintigraphy NA [8,9] Cholestasis Cholescintigraphy PET-CT [8,10] Hepatic fibrosis Ultrasound elastography MRI, MRE [11][12][13][14][15][16] Liver cancer Ultrasonography CT/MRI [13,17] Liver metastasis MRI/CT NA [15,18] Liver steatosis Ultrasonography NA [12] Obstructed/dilated ducts Cholescintigraphy NA [19,20] ERCP: endoscopic retrograde cholangiopancreatography; MRE: magnetic resonance elastography; NA: none available; PET: positron emission tomography; PTC: percutaneous transhepatic cholangiography Some alternative tests used in liver function evaluation are classical, such as these performed using hepatotropic agents, i.e., efficiently accumulated by the liver or cholephilic compounds, i.e., substances in most part taken up by the liver and secreted into bile. A significant limitation in using these agents to estimate whole liver function is that most of them are not homogeneously distributed throughout the hepatobiliary system.…”
Section: Liver Pathology Image Techniques Alternatives Referencesmentioning
confidence: 99%
“…Biliary leak Cholescintigraphy NA [5] Gallstones ERCP PTC [6,7] Cholecystitis Cholescintigraphy NA [8,9] Cholestasis Cholescintigraphy PET-CT [8,10] Hepatic fibrosis Ultrasound elastography MRI, MRE [11][12][13][14][15][16] Liver cancer Ultrasonography CT/MRI [13,17] Liver metastasis MRI/CT NA [15,18] Liver steatosis Ultrasonography NA [12] Obstructed/dilated ducts Cholescintigraphy NA [19,20] ERCP: endoscopic retrograde cholangiopancreatography; MRE: magnetic resonance elastography; NA: none available; PET: positron emission tomography; PTC: percutaneous transhepatic cholangiography Some alternative tests used in liver function evaluation are classical, such as these performed using hepatotropic agents, i.e., efficiently accumulated by the liver or cholephilic compounds, i.e., substances in most part taken up by the liver and secreted into bile. A significant limitation in using these agents to estimate whole liver function is that most of them are not homogeneously distributed throughout the hepatobiliary system.…”
Section: Liver Pathology Image Techniques Alternatives Referencesmentioning
confidence: 99%
“…On CT, non‐rim‐like hyperenhancement in the arterial phase and washout in the portal‐venous and delayed phases are the key indicators of HCC. About 40% of HCCs have unusual morphological characteristics, however, which makes diagnosis difficult for radiologists 36,37 . Most HCC lesions exhibit the standard MRI features of arterial enhancement with washout in the portal venous phase, hypointensity on T1‐weighted images, and hyperintensity on T2‐weighted images 20 …”
Section: Ct and Mri Imagingmentioning
confidence: 99%
“…About 40% of HCCs have unusual morphological characteristics, however, which makes diagnosis difficult for radiologists. 36,37 Most HCC lesions exhibit the standard MRI features of arterial enhancement with washout in the portal venous phase, hypointensity on T1-weighted images, and hyperintensity on T2-weighted images. 20 On cross-sectional imaging, it may be challenging to distinguish infiltrating HCC from underlying heterogeneous cirrhosis.…”
Section: Ct and Mri Imagingmentioning
confidence: 99%
See 1 more Smart Citation
“…[ 5 ] A recent Cochrane meta‐analysis has reported that detection sensitivity is 78% and specificity is 91% for HCC lesions of any size. [ 6 ] For analysis focusing on small lesions, sensitivity has been reported to be as low as 40%. [ 7 ] Thus, HCC lesions are at danger of being missed at an early course of the disease when treatment is most promising.…”
Section: Introductionmentioning
confidence: 99%